Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Someone Is Trying To Halt TLT'S Recent RUN
View:
Post by skys1 on Jun 02, 2022 2:31pm

Someone Is Trying To Halt TLT'S Recent RUN

Someone just put a 271K ask up on the US side. I think that is the biggest I have seen. If it was legit and you did want to lighten your posirion by 271K, you wouldn't put it all out there at once because it would scare many buyers. You would put 1/3, or 1/4 at a time. If someone put a bid of 100K up you could put a 100K ask, but other than a situation like that, I think this is done for a reason, and a big short would easily have that much to offer.
Comment by fredgoodwinson on Jun 02, 2022 2:34pm
The manipuition is getting clumsier as their options narrow and their timelines shorten.
Comment by Rumpl3StiltSkin on Jun 02, 2022 2:38pm
Seems they agree with ya Skys, now that ask is 135k.... 
Comment by skys1 on Jun 02, 2022 2:47pm
Now it has disappeared with no change in volume. What does that tell you. It was just put up for about 10 or 15 minutes just to scare buyers.
Comment by GabbyGab on Jun 02, 2022 3:04pm
They will ran out of tricks very soon. ''Normal'' people don't even look at level 2. In my opinion, the BTD start to be priced in.
Comment by LaserStock29 on Jun 02, 2022 3:54pm
Did u imply the BTD is priced in. Um no that would be $2 Market cap 500m for a phase 2 and 900m for stage 3 as it was at cambridge 2014 And process have only gone up What the hell am I reading
Comment by GabbyGab on Jun 02, 2022 4:20pm
Allright tony, so what is your guess about that run ? So when we get BTD we go at 2$ ? NIce
Comment by LaserStock29 on Jun 02, 2022 3:59pm
If it was 2019 I'd think people were getting out to have cash for a pp with warrants No nothing like that this time
Comment by StevenBirch on Jun 02, 2022 4:38pm
That's why I think this is accumulation and not short covering. What is the short position anyway? We've had decent volume recently, is there that many shares short? I think they saw some juicy mid-size offerings every half cent up to 5 cents or thereabouts and decided to take it. Just as a big offer will scare away buyers a big bid will make sellers hesitant so they will stick in a big ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250